SG11202108287WA - Cannabinoid receptor agonists and serine hydrolase enzyme inhibitor based anxiolytic therapeutic product - Google Patents
Cannabinoid receptor agonists and serine hydrolase enzyme inhibitor based anxiolytic therapeutic productInfo
- Publication number
- SG11202108287WA SG11202108287WA SG11202108287WA SG11202108287WA SG11202108287WA SG 11202108287W A SG11202108287W A SG 11202108287WA SG 11202108287W A SG11202108287W A SG 11202108287WA SG 11202108287W A SG11202108287W A SG 11202108287WA SG 11202108287W A SG11202108287W A SG 11202108287WA
- Authority
- SG
- Singapore
- Prior art keywords
- receptor agonists
- enzyme inhibitor
- cannabinoid receptor
- therapeutic product
- inhibitor based
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16/270,389 US11147805B2 (en) | 2019-02-07 | 2019-02-07 | Cannabinoid receptor agonists and serine hydrolase enzyme inhibitor based anxiolytic therapeutic product |
| PCT/CA2020/050165 WO2020160677A1 (en) | 2019-02-07 | 2020-02-07 | Cannabinoid receptor agonists and serine hydrolase enzyme inhibitor based anxiolytic therapeutic product |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202108287WA true SG11202108287WA (en) | 2021-08-30 |
Family
ID=71944747
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202108287WA SG11202108287WA (en) | 2019-02-07 | 2020-02-07 | Cannabinoid receptor agonists and serine hydrolase enzyme inhibitor based anxiolytic therapeutic product |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US11147805B2 (en) |
| EP (1) | EP3920925A4 (en) |
| JP (1) | JP2022519873A (en) |
| CN (1) | CN113573710A (en) |
| AR (1) | AR118037A1 (en) |
| AU (1) | AU2020218381A1 (en) |
| BR (1) | BR112021015387A2 (en) |
| CA (1) | CA3129368A1 (en) |
| IL (1) | IL285261A (en) |
| MX (1) | MX2021009394A (en) |
| SG (1) | SG11202108287WA (en) |
| TW (1) | TW202045147A (en) |
| WO (1) | WO2020160677A1 (en) |
| ZA (1) | ZA202106382B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11977085B1 (en) | 2023-09-05 | 2024-05-07 | Elan Ehrlich | Date rape drug detection device and method of using same |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10051427C1 (en) | 2000-10-17 | 2002-06-13 | Adam Mueller | Process for the production of an extract containing tetrahydrocannabinol and cannabidiol from cannabis plant material and cannabis extracts |
| CZ306277B6 (en) | 2001-02-14 | 2016-11-09 | Gw Pharma Limited | Pump-action spray formulation |
| GB2393182B (en) | 2002-09-23 | 2007-03-14 | Gw Pharma Ltd | Method of preparing cannabidiol from plant material |
| GB0222077D0 (en) | 2002-09-23 | 2002-10-30 | Gw Pharma Ltd | Methods of preparing cannabinoids from plant material |
| US20090082435A1 (en) | 2005-04-28 | 2009-03-26 | The Regents Of The University Of California | Methods, Compositions, And Compounds For Modulation Of Monoacylglycerol Lipase, Pain, And Stress-Related Disorders |
| CA2702946A1 (en) | 2007-10-16 | 2009-04-23 | Northeastern University | Monoacylglycerol lipase inhibitors for modulation of cannabinoid activity |
| JP5576874B2 (en) | 2008-11-14 | 2014-08-20 | ザ スクリプス リサーチ インスティテュート | Methods and compositions related to drug targeting of monoacylglycerol lipase |
| EP2609912A1 (en) | 2011-12-30 | 2013-07-03 | Deva Holding Anonim Sirketi | Pharmaceutical combination of fingolimod and nabiximols |
| US20150313868A1 (en) * | 2012-12-18 | 2015-11-05 | Kotzker Consulting Llc | Use of cannabinoids and terpenes for treatment of organophosphate and carbamate toxicity |
| US20160000803A1 (en) | 2013-02-22 | 2016-01-07 | Eastgate Pharmaceuticals Inc. | Pharmaceutical composition for transmucosal administration of benzodiazepines |
| ES2610988T3 (en) | 2013-10-29 | 2017-05-04 | Echo Pharmaceuticals B.V. | Tablet containing cannabidiol, method for its production and use of such tablet in the oral treatment of psychotic or anxiety disorders |
| GB2557921A (en) | 2016-12-16 | 2018-07-04 | Gw Res Ltd | Use of cannabinoids in the treatment of angelman syndrome |
| US20190029993A1 (en) * | 2017-07-26 | 2019-01-31 | Richard Postrel | Quality of life extension therapies relating to aging, food allergies, pain and reduced vigor by managing molecular, cellular and subcellular biochemical requirements of mitochondria and other organelle processes |
-
2019
- 2019-02-07 US US16/270,389 patent/US11147805B2/en active Active
- 2019-10-31 US US16/670,679 patent/US20200253948A1/en not_active Abandoned
-
2020
- 2020-02-07 BR BR112021015387-0A patent/BR112021015387A2/en not_active Application Discontinuation
- 2020-02-07 CA CA3129368A patent/CA3129368A1/en active Pending
- 2020-02-07 AR ARP200100344A patent/AR118037A1/en unknown
- 2020-02-07 EP EP20752873.8A patent/EP3920925A4/en not_active Withdrawn
- 2020-02-07 AU AU2020218381A patent/AU2020218381A1/en not_active Abandoned
- 2020-02-07 MX MX2021009394A patent/MX2021009394A/en unknown
- 2020-02-07 WO PCT/CA2020/050165 patent/WO2020160677A1/en unknown
- 2020-02-07 CN CN202080021871.5A patent/CN113573710A/en active Pending
- 2020-02-07 TW TW109103948A patent/TW202045147A/en unknown
- 2020-02-07 JP JP2021545972A patent/JP2022519873A/en active Pending
- 2020-02-07 SG SG11202108287WA patent/SG11202108287WA/en unknown
-
2021
- 2021-08-01 IL IL285261A patent/IL285261A/en unknown
- 2021-09-01 ZA ZA2021/06382A patent/ZA202106382B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3920925A4 (en) | 2022-11-23 |
| AR118037A1 (en) | 2021-09-15 |
| BR112021015387A2 (en) | 2021-09-28 |
| WO2020160677A1 (en) | 2020-08-13 |
| US20200253948A1 (en) | 2020-08-13 |
| CA3129368A1 (en) | 2020-08-13 |
| US11147805B2 (en) | 2021-10-19 |
| IL285261A (en) | 2021-09-30 |
| AU2020218381A1 (en) | 2021-09-09 |
| CN113573710A (en) | 2021-10-29 |
| ZA202106382B (en) | 2022-06-29 |
| EP3920925A1 (en) | 2021-12-15 |
| MX2021009394A (en) | 2021-11-18 |
| TW202045147A (en) | 2020-12-16 |
| US20200253947A1 (en) | 2020-08-13 |
| JP2022519873A (en) | 2022-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202108443B (en) | Protein tyrosine phosphatase inhibitors | |
| SG11202109067PA (en) | Protein tyrosine phosphatase inhibitors and methods of use thereof | |
| EP3909259A4 (en) | Method for detecting wearing of acoustic device and acoustic device supporting the same | |
| EP3615025A4 (en) | Nrf and hif activators/hdac inhibitors and therapeutic methods using the same | |
| IL289914A (en) | Enzyme inhibitors | |
| EP3962481A4 (en) | Kcnt1 inhibitors and methods of use | |
| EP3962479A4 (en) | Kcnt1 inhibitors and methods of use | |
| EP3735242A4 (en) | Metallo-beta-lactamase inhibitors and methods of use thereof | |
| EP3909007A4 (en) | System for targeted display of content | |
| MX2017013875A (en) | Certain protein kinase inhibitor. | |
| EP3810615A4 (en) | Arginase inhibitors and methods of use | |
| IL289863A (en) | Enzyme inhibitors | |
| MX2019006421A (en) | Cleaning compositions including enzymes. | |
| EP3337791A4 (en) | Inhibitors of peptidyl arginine deiminase (pad) enzymes and uses thereof | |
| IL289778A (en) | Enzyme inhibitors | |
| IL289783A (en) | Enzyme inhibitors | |
| ZA202106450B (en) | Systems and methods for integrated and comprehensive management of cannabis products | |
| EP3816282A4 (en) | Enzymes of luciferin biosynthesis and use thereof | |
| ZA202106382B (en) | Cannabinoid receptor agonists and serine hydrolase enzyme inhibitor based anxiolytic therapeutic product | |
| EP3820475A4 (en) | Administration of sumo-activating enzyme inhibitor and anti-cd20 antibodies | |
| EP3825943A4 (en) | Method and device for dynamically determining price of item | |
| IL286485A (en) | Pi4-kinase inhibitors and methods of using the same | |
| EP4074837A4 (en) | Modified daao enzyme and application thereof | |
| GB201709136D0 (en) | New therapeutic uses of enzyme inhibitors | |
| EP4014189A4 (en) | Systems and methods for targeting promotional material |